Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-11-13
1993-04-20
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, A61K 3702, C07K 710
Patent
active
052043274
ABSTRACT:
A pharmaceutical composition and its use in the treatment of cerebral edema are provided wherein the composition comprises an atrial natriuretic peptide having an amino acid sequence of 28 amino acids and at least one pharmaceutically acceptable carrier, diluent or excipient.
REFERENCES:
patent: 4663437 (1987-05-01), de Bold
Doczi et al. Neurosurgery, vol. 21, #4, Oct. (1987) pp. 454-458.
Doczi et al. Acta Neurochirurgica, vol. 43, Supplement 43, 1980, pp. 186-458.
Klatzo, I., "Neuropathological aspects of brain edema," J. Neuropath, Exp. Neurol., 26, 1-14 (1967).
Fishman, R. A., "Brain edema," New England J. Med., 293, 706-(1975).
Marc Cantin and Jacques Genest, "The Heart as an Endocrine Gland," Scientific American, 254, 62-67 (1986).
Bianchi, C., et al., "Radiautographic Localization of .sup.125 I-Atrial Natriuretic Factor Binding Sites in the Brain," Neuroendocrinology, 44 365-372 (1986).
Steardo, L. and Nathanson, J. A., "Brain Barrier Tissues: End Organs for Atriopeptins," Science, 235, 470-473 (1987) p. 11.
Watanabe et al., Eur. J. Pharmacol., 147, 49-57 (1988).
Imai, T. et al., "Effect on ANP on kidney," Protein-Nucleic Acid-Enzyme, 113 (14), 2476-2489 (1988).
Hayashi Hiroshi
Kiyota Takao
Sugawara Shuichi
Ashi Kasei Kogyo Kabushiki Kaisha
Lee Lester L.
LandOfFree
Treatment of cerebral edema with ANP pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cerebral edema with ANP pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cerebral edema with ANP pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526174